Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.74 USD | -5.39% | -1.25% | -6.14% |
Business Summary
Number of employees: 267
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Stereopure Oligonucleotides
100.0
%
| 4 | 100.0 % | 113 | 100.0 % | +3,005.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Singapore, United States, Japan, United Kingdom, and Ireland
100.0
%
| 4 | 100.0 % | 113 | 100.0 % | +3,005.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Bolno
CEO | Chief Executive Officer | 50 | 13-11-30 |
Kyle Moran
DFI | Director of Finance/CFO | 54 | 14-06-30 |
Chandra Vargeese
CTO | Chief Tech/Sci/R&D Officer | 63 | 14-07-31 |
Kate Rausch
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | 22-01-31 | |
Corporate Officer/Principal | 46 | 14-03-31 | |
Linda K. Rockett
LAW | General Counsel | - | 16-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
CHM | Chairman | 56 | 16-11-09 |
Mark Corrigan
BRD | Director/Board Member | 66 | 19-09-03 |
Adrian Rawcliffe
BRD | Director/Board Member | 52 | 17-01-31 |
Gregory Verdine
FOU | Founder | 65 | 12-07-22 |
Peter Kolchinsky
BRD | Director/Board Member | 47 | 14-12-31 |
Paul Bolno
CEO | Chief Executive Officer | 50 | 13-11-30 |
Heidi Wagner
BRD | Director/Board Member | 59 | 19-09-03 |
Ken Takanashi
BRD | Director/Board Member | 59 | 12-06-30 |
Aik Na Tan
BRD | Director/Board Member | 53 | 20-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 122,284,139 | 100,024,528 ( 81.80 %) | 0 | 81.80 % |
Stock B | 0 | 3,901,348 | 0 | 0 |
Company contact information
Wave Life Sciences Ltd.
Marina One East Tower 7 Straits View
018936, Singapore
+65 6236 3388
http://www.wavelifesciences.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.14% | 613M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- WVE Stock
- Company Wave Life Sciences Ltd.